Covalent binding of non-proteolysed C3 to Jurkat T cells

doi:10.1016/0161-5890(91)90113-X

Molecular Immunology

Volume 28, Issue 7, July 1991, Pages 711-717

https://doi.org/10.1016/0161-5890(91)90113-X Get rights and content

Abstract

Purified C3 binds covalently to Jurkat T cells upon incubation at neutral pH. This binding does not appear to involve proteolysis of C3; it leads to high-molecular-weight associations, preferentially through ester linkages, which are disrupted upon incubation with hydroxylamine at alkaline pH. Part of the association also appears to involve disulfide links between C3 and Jurkat cells. Similarly, plasma membranes purified from these cells bind C3 with no evidence for proteolysis of C3. Binding of C3 appears to be “catalysed” by Jurkat cells, and is not due to the well-known spontaneous hydrolysis of C3. Binding of C3 involves hydrolysis of its thioester bond, as titratable —SH groups are available in soluble C3 after incubation of purified C3 with Jurkat plasma membranes; loss of C3 haemolytic activity confirms this finding. These observations give evidence for the binding of C3b-like C3 to Jurkat cells, conferring on these cells the potential to interact with other complement receptor-bearing cells such as B cells.

References (34)

A. Al Salihi et al.
Purification of complement components by hydrophobic affinity chromatography on phenyl-Sepharose
FEBS Lett.
(1982)
J. Avruch et al.
Preparation and properties of plasma membrane and endoplasmic reticulum fragments from isolated rat fat cells
Biochim. biophys. Acta
(1971)
M.M. Bradford
A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein dye binding
Analyt. Biochem.
(1976)
J.H.M. Cohen et al.
Enumeration of CR1 complement receptors on erythrocytes using a new method for detecting low density cell surface antigens by flow cytometry
J. Immun. Meth.
(1987)
A. Erdei et al.
Appearance of acceptor-bound C3b on HLA-DR positive macrophages and on stimulated U937 cells; inhibition of Fc γ-receptors by the covalently fixed C3 fragments
Molec. Immun.
(1988)
R.B. Freedman
Protein disulfide isomerase: multiple roles in the modification of nascent secretory proteins
Cell
(1989)
D.E. Isenman
Conformational changes accompanying proteolytic cleavage of human complement protein C3b by the regulatory enzyme factor I and its cofactor H
J. biol. Chem.
(1983)
D.E. Isenman et al.
The structure and function of the third component of human complement—I. The nature and extent of conformational changes accompanying C3 activation
Molec. Immun.
(1981)
T.E. Jessen et al.
A simple alternative pathway for hemolytic assay of human complement component C3 using methylamine-treated plasma
J. Immun. Meth.
(1983)
J.O. Minta et al.
Biosynthesis of the third component of complement by the human monocyte-like cell line, U937
Molec. Immun.
(1987)

J.L. Molenaar et al.

Physicochemical and antigenic properties of human C3

Immunochemistry

(1975)

P. Pantazis et al.

Synthesis of the third component of complement (C3) by lectin-activated and HTLV-infected human T-cells

Molec. Immun.

(1990)

H.S. Penefsky

Reversible binding of Pi by beef heart mitochondrial adenosine triphosphatase

J. biol. Chem.

(1977)

K.B.M. Reid et al.

Structure function relationships of the complement components

Immun. Today

(1989)

G.D. Ross et al.

Membrane complement receptors specific for bound fragments of C3

Adv. Immun.

(1985)

E. Tatsumi et al.

Catalogue of Epstein-Barr virus (EBV) receptors on human malignant and non-malignant haematopoietic cell lines

Leuk. Res.

(1985)

Y.P. Venkatesh et al.

The esterase-like activity of covalently bound human third complement protein

Molec. Immun.

(1988)

Cited by (8)

A novel, complement-mediated way to enhance the interplay between macrophages, dendritic cells and T lymphocytes
2009, Molecular Immunology
Recently it has been reported that human C3-deficiency is associated with impairments in dendritic cell differentiation. Here we investigated how complement C3 influences the phenotype and functional activity of human dendritic cells. We show that human monocyte-derived dendritic cells (MDCs) when incubated with native, hemolytically active C3, bind the activation fragments of C3 covalently. This reaction directs MDCs to increase expression of MHCII, CD83 and CD86, moreover it results in a significantly enhanced secretion of TNF-α, IL-6 and IL-8. A further functional consequence of C3b-fixation is the elevated capacity of the dendritic cells to stimulate allogeneic T cells. The distinct role of covalently fixed C3-fragments is strongly supported by our results obtained with MDCs where CD11b expression was downregulated by siRNA. To reveal the possible in vivo significance of the present findings we modelled a phenomenon occurring during inflammation, where C3 is produced locally by activated macrophages. In these cocultures MDCs were found to fix substantial amounts of macrophage derived C3-fragments on their cell membrane. Our data provide compelling evidence that antigen presenting cells arising in complement-sufficient environment mature to competent stimulators of T cells.
The role of antigen-bound C3b in antigen processing
1996, Research in Immunology
Defective glycosyl phospharidylinositol anchor synthesis and paroxysmal nocturnal hemoglobinuria
1995, Advances in Immunology
The glycosyl phosphatidylinositol (GPI) anchor is synthesized in the endoplasmic reticulum (ER) and post-translationally linked to the nascent peptides in the ER. If the peptides are not GPI anchored, they are not expressed on the cell surface due to intracellular retention, degradation, and secretion. The human disease, paroxysmal nocturnal hemoglobinuria (PNH), is caused by this mechanism. PNH is a hematopoietic stem cell disorder characterized by the presence of abnormal cells of various hematopoietic cell lineages that are deficient in the surface expression of GPI-anchored proteins. The abnormal red blood cells of patients with PNH are sensitive to the hemolytic action of complement due to the deficient surface expression of decay accelerating factor and CD59, which are GPI-anchored complement inhibitors. The first step of GPI anchor biosynthesis is deficient in abnormal blood cells from patients with PNH. The X-linked gene PIG-A is cloned and somatically mutated in abnormal cells from patients with PNH. Due to its X-chromosomal location, a single inactivating mutation results in a loss of GPI anchor synthesis, even in a female hematopoietic stem cell, if it occurs in the active allele of the PIG-A gene. More than 60 patients with PNH from various countries were analyzed and the PIG-A gene was responsible for PNH in all of them. The X-chromosomal location of the PIG-A gene would also account for this uniformity of the responsible gene among the 10 or so genes involved in GPI anchor synthesis. Patients with PNH have one or more mutant hematopoietic stem cell clones that are deficient in GPI anchor synthesis due to somatic mutations in the X-linked gene, PIG-A. The somatic mutations of PIGA are widely distributed in the coding regions and splice sites, indicating that they occur at random sites.
Macrophage-Bound C3 Fragments as Adhesion Molecules Modulate Presentation of Exogenous Antigens
1992, Immunobiology
The involvement of complement in the response to T cell dependent antigens is generally accepted, however the mechanism has not been clarified. We compared the T cell response in vitro, using antigen-pulsed macrophages from normal and genetically C3-deficient guinea pigs, and show, that C3-fragments fixed covalently to the surface of the antigen-presenting cells are involved in the triggering of responder T cells. Binding of guinea pig C3-specific mAb to oilelicited, OVA- and PPD-pulsed macrophages of C3D guinea pigs is reduced compared to normal cells, while the expression of Ia antigens is the same. C3-like peptides can be immunoprecipitated only from the lysate of oil-elicited normal cells. These C3-fragments are fixed to the cell-membrane via ester-bonds, since they are released upon treatment with hydroxylamine. In comparison with normal cells, the antigen-presenting capacity of macrophages derived from C3D animals is strongly impaired in cultures containing 10% normal guinea pig serum. A further impairment is observed in cultures with 10% C3D guinea pig serum. Two of the tested C3-specific mAb inhibited antigen-induced T cell proliferation in a dose-dependent manner.
Our data point to the importance of C3, as a bivalent molecule, having the capacity to facilitate the cooperation between the antigen-presenting cell and the responder T lymphocytes.
The versatile functions of complement C3-derived ligands
2016, Immunological Reviews
Covalent binding of C3b to tetanus toxin: Influence on uptake/internalization of antigen by antigen-specific and non-specific B cells
1996, Immunology

View all citing articles on Scopus

View full text

Covalent binding of non-proteolysed C3 to Jurkat T cells

Abstract

FEBS Lett.

Biochim. biophys. Acta

Analyt. Biochem.

J. Immun. Meth.

Molec. Immun.

Cell

J. biol. Chem.

Molec. Immun.

J. Immun. Meth.

Molec. Immun.

Immunochemistry

Molec. Immun.

J. biol. Chem.

Immun. Today

Adv. Immun.

Leuk. Res.

Molec. Immun.